Earnings Call · Q4 FY2021·2022-02-28

Q4 21EPS -100.00%*·Rev n/aQ3 21EPS +100.00%*·Rev n/aQ2 21EPS -100.00%*·Rev n/aQ1 21EPS +10.34%·Rev n/a⚠ consensus missing

KYNTRA BIO, INC. FGEN

Michael Tung — Vice President of Corporate Strategy and Investor Relations

Enrique Conterno — Chief Executive Officer

Juan Graham — Chief Financial Officer

−3.2%1d on move date−1.7% vs SPY3d−6.5%5d−9.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FGEN calls or request research access.

More FGEN calls Browse calls Request research access